Stent thrombosis with bioabsorbable polymer drug-eluting stents: insights from the Food and Drug Administration database

BackgroundSYNERGY, a bioabsorbable polymer-based, everolimus-eluting stent (BP-DES), recently received regulatory approval in the USA for use in percutaneous coronary interventions. Yet, information on the safety of BP-DES in routine clinical practice is limited. Our aim was to compare the safety of